重组Anti-Insulin degrading enzyme / IDE抗体[EPR6099]
Anti-Insulin degrading enzyme / IDE antibody [EPR6099]
- RabMAb
- Recombinant
- KO Validated
- 了解详情
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal Insulin degrading enzyme / IDE antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 4 publications.
查看别名
Insulin-degrading enzyme, Abeta-degrading protease, Insulin protease, Insulysin, Insulinase, IDE
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (AB109538)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling Insulin degrading enzyme / IDE with purified ab109538 at 1/150 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti-rabbit IgG (Alexa Fluorr® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- WB
Lab
Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (AB109538)
Lanes 1 - 4 : Merged signal (red and green). Green - ab109538 observed at 118 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab109538 was shown to specifically react with IDE in wild-type HAP1 cells. No band was observed when IDE knockout samples were examined. Wild-type and IDE knockout samples were subjected to SDS-PAGE. ab109538 and ab8245 (loading control to GAPDH) were both diluted 1/2000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538) at 1/2000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
IDE knockout HAP1 cell lysate at 20 µg
Lane 3:
K562 cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Predicted band size: 118 kDa
false
- WB
Lab
Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (AB109538)
Lanes 1- 2 : Merged signal (red and green). Green - ab109538 observed at 118 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab109538 was shown to react with Insulin degrading enzyme / IDE in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261755 (knockout cell lysate ab257197) was used. Wild-type HeLa and IDE knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab109538 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
IDE knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human IDE (Insulin degrading enzyme) knockout HeLa cell line (<a href='/products/cell-lines/human-ide-insulin-degrading-enzyme-knockout-hela-cell-line-ab261755'>ab261755</a>)
Predicted band size: 118 kDa
Observed band size: 118 kDa
false
- WB
Unknown
Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (AB109538)
All lanes:
Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
HepG2 cell lysate at 10 µg
Lane 3:
A375 cell lysate at 10 µg
Lane 4:
K562 cell lysate at 10 µg
Secondary
All lanes:
HRP-labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 118 kDa
false
不同偶联物与剂型 (2)
-
HRP Anti-Insulin degrading enzyme / IDE antibody [EPR6099]
-
Anti-Insulin degrading enzyme / IDE antibody [EPR6099] - BSA and Azide free
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IDE manages the levels of insulin and other peptides by degrading them preventing accumulation and maintaining homeostasis. It is not part of a complex but it acts individually in cellular environments to modulate the concentration of its substrates. IDE is important for controlling insulin availability and turnover which impacts glucose metabolism. By influencing the degradation of insulin IDE aids in balancing metabolic demands with insulin availability.
Pathways
IDE plays a vital role in insulin signaling and glucose metabolic processes. It is directly involved in the insulin signaling pathway by regulating insulin levels which consequently affects cellular responses to insulin. IDE connects with several proteins associated with these pathways including insulin receptor and glucose transporters ensuring proper cell signaling and metabolic functions. By modulating insulin levels IDE helps optimize glucose uptake and storage.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (4)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 13:1057 PubMed36539418
2022
Applications
Unspecified application
Species
Unspecified reactive species
Brain pathology (Zurich, Switzerland) 32:e13032 PubMed34713522
2021
Applications
Unspecified application
Species
Unspecified reactive species
Behavioural neurology 2021:6683318 PubMed33880134
2021
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica communications 6:44 PubMed29855361
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com